300006 莱美药业
已收盘 05-19 15:00:00
资讯
新帖
简况
莱美药业最新公告：全资子公司获醋酸曲普瑞林原料药上市批准
证券之星 · 05-15
莱美药业最新公告：全资子公司获醋酸曲普瑞林原料药上市批准
股市必读：莱美药业（300006）5月14日董秘有最新回复
证券之星 · 05-15
股市必读：莱美药业（300006）5月14日董秘有最新回复
莱美药业：截至2026年4月30日，公司股东户数为24,889
证券之星 · 05-14
莱美药业：截至2026年4月30日，公司股东户数为24,889
莱美药业：截至2026年4月30日，公司股东户数为24,889
证券之星 · 05-07
莱美药业：截至2026年4月30日，公司股东户数为24,889
莱美药业（300006）2026年一季报简析：净利润同比下降8.98%
证券之星 · 04-24
莱美药业（300006）2026年一季报简析：净利润同比下降8.98%
莱美药业(300006.SZ)发布一季度业绩，归母净亏损1501.27万元
智通财经 · 04-22
莱美药业(300006.SZ)发布一季度业绩，归母净亏损1501.27万元
莱美药业（300006）披露2025年年度股东会决议公告，4月21日股价下跌0.77%
证券之星 · 04-21
莱美药业（300006）披露2025年年度股东会决议公告，4月21日股价下跌0.77%
莱美药业：截至2026年4月10日，公司股东户数为33,535
证券之星 · 04-16
莱美药业：截至2026年4月10日，公司股东户数为33,535
莱美药业（300006）披露股票交易异常波动公告，4月7日股价下跌7.67%
证券之星 · 04-07
莱美药业（300006）披露股票交易异常波动公告，4月7日股价下跌7.67%
莱美药业最新公告：公司及控股股东不存在应披露而未披露的重大事项
证券之星 · 04-03
莱美药业最新公告：公司及控股股东不存在应披露而未披露的重大事项
股市必读：3月27日莱美药业发布公告，股东减持0万股
证券之星 · 03-30
股市必读：3月27日莱美药业发布公告，股东减持0万股
3月27日莱美药业发布公告，股东减持0万股
证券之星 · 03-27
3月27日莱美药业发布公告，股东减持0万股
三部门发文规范中医药服务管理；药监局助力器械临床创新成果转化
21世纪经济报道 · 03-25
三部门发文规范中医药服务管理；药监局助力器械临床创新成果转化
莱美药业最新公告：注射用氨曲南通过仿制药一致性评价
证券之星 · 03-24
莱美药业最新公告：注射用氨曲南通过仿制药一致性评价
莱美药业：截至2026年3月20日，公司股东户数为28,245
证券之星 · 03-24
莱美药业：截至2026年3月20日，公司股东户数为28,245
股市必读：莱美药业年报 - 第四季度单季净利润同比下降44.63%
证券之星 · 03-20
股市必读：莱美药业年报 - 第四季度单季净利润同比下降44.63%
莱美药业(300006.SZ)发布2025年度业绩，归母净亏损1.35亿元
智通财经 · 03-18
莱美药业(300006.SZ)发布2025年度业绩，归母净亏损1.35亿元
每周股票复盘：中恒集团（600252）莱美药业拟投500万设生物医药基金
证券之星 · 03-15
每周股票复盘：中恒集团（600252）莱美药业拟投500万设生物医药基金
莱美药业最新公告：参与投资设立创业投资基金
证券之星 · 03-11
莱美药业最新公告：参与投资设立创业投资基金
莱美药业：截至2026年3月10日，公司股东户数为28,115
证券之星 · 03-11
莱美药业：截至2026年3月10日，公司股东户数为28,115
加载更多
公司概况
公司名称：
重庆莱美药业股份有限公司
所属行业：
医药制造业
上市日期：
2009-10-30
主营业务：
重庆莱美药业股份有限公司的主营业务是医药制造。公司的主要产品是化药，涵盖特色专科类（主要包括抗肿瘤药、消化系统药、肠外营养药）、抗感染类等。
发行价格：
16.50
{"stockData":{"symbol":"300006","market":"SZ","secType":"STK","nameCN":"莱美药业","latestPrice":5.98,"timestamp":1779174210000,"preClose":6.01,"halted":0,"volume":24140314,"delay":0,"changeRate":-0.005,"floatShares":1056000000,"shares":1056000000,"eps":-0.1288,"marketStatus":"已收盘","change":-0.03,"latestTime":"05-19 15:00:00","open":5.98,"high":6.15,"low":5.91,"amount":145000000,"amplitude":0.0399,"askPrice":5.99,"askSize":327,"bidPrice":5.98,"bidSize":3834,"shortable":0,"etf":0,"ttmEps":-0.1288,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.01,"symbolType":"stock","openAndCloseTimeList":[[1779154200000,1779161400000],[1779166800000,1779174000000]],"highLimit":6.61,"lowLimit":5.41,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1055911205,"isCdr":false,"pbRate":3.65,"roa":"--","roe":"--","epsLYR":-0.1276,"committee":0.097885,"marketValue":6314000000,"turnoverRate":0.0229,"status":1,"floatMarketCap":6314000000},"requestUrl":"/m/hq/s/300006","defaultTab":"news","newsList":[{"id":"2635170761","title":"莱美药业最新公告：全资子公司获醋酸曲普瑞林原料药上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2635170761","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635170761?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:13","pubTimestamp":1778836380,"startTime":"0","endTime":"0","summary":"莱美药业(300006.SZ)公告称，公司全资子公司莱美隆宇收到国家药监局核准签发的醋酸曲普瑞林《化学原料药上市申请批准通知书》，该原料药符合药品注册要求，批准注册。醋酸曲普瑞林制剂用于不育症治疗中的垂体降调节等。截至目前，除莱美隆宇外，另有10家企业该原料药已获批上市。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500030550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635747078","title":"股市必读：莱美药业（300006）5月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2635747078","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635747078?lang=zh_cn&edition=full","pubTime":"2026-05-15 02:46","pubTimestamp":1778784373,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，莱美药业报收于6.39元，下跌1.39%，换手率3.19%，成交量33.67万手，成交额2.16亿元。董秘最新回复投资者： 你好，请问一下贵公司4月30日的股东人数是多少？投资者： 尊敬的董秘你好，请问截止至2026年5月10日收盘公司股东人数为多少，谢谢！截至2026年5月8日，公司股东户数为24,958。当日关注点来自交易信息汇总：5月14日主力资金净流出916.01万元，游资资金净流入1709.92万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500002243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635792429","title":"莱美药业：截至2026年4月30日，公司股东户数为24,889","url":"https://stock-news.laohu8.com/highlight/detail?id=2635792429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635792429?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:39","pubTimestamp":1778747952,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月30日公司的股东总数是多少？谢谢莱美药业回复：尊敬的投资者，您好。截至2026年4月30日，公司股东户数为24,889。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400028799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633193520","title":"莱美药业：截至2026年4月30日，公司股东户数为24,889","url":"https://stock-news.laohu8.com/highlight/detail?id=2633193520","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633193520?lang=zh_cn&edition=full","pubTime":"2026-05-07 11:34","pubTimestamp":1778124885,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)05月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年4月 30日公司的股东总数是多少？谢谢莱美药业回复：尊敬的投资者，您好。截至2026年4月30日，公司股东户数为24,889。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700015346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629831828","title":"莱美药业（300006）2026年一季报简析：净利润同比下降8.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629831828","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629831828?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:34","pubTimestamp":1777041287,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期莱美药业发布2026年一季报。根据财报显示，莱美药业净利润同比下降8.98%。截至本报告期末，公司营业总收入1.82亿元，同比下降8.16%，归母净利润-1501.27万元，同比下降8.98%。本次财报公布的各项数据指标表现不尽如人意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629409820","title":"莱美药业(300006.SZ)发布一季度业绩，归母净亏损1501.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629409820","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629409820?lang=zh_cn&edition=full","pubTime":"2026-04-22 22:27","pubTimestamp":1776868055,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布2026年第一季度报告，该公司营业收入为1.82亿元，同比减少8.16%。归属于上市公司股东的净亏损为1501.27万元。归属于上市公司股东的扣除非经常性损益的净亏损为1547.03万元。基本每股亏损为0.0142元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629030622","title":"莱美药业（300006）披露2025年年度股东会决议公告，4月21日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629030622","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629030622?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:14","pubTimestamp":1776780861,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘，莱美药业报收于6.44元，较前一交易日下跌0.77%，最新总市值为68亿元。该股当日开盘6.56元，最高6.58元，最低6.26元，成交额达3.28亿元，换手率为4.87%。近日，重庆莱美药业股份有限公司发布《2025年年度股东会决议公告》。出席会议股东及授权代表共157人，代表股份占公司总股本的23.9933%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100052978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627039298","title":"莱美药业：截至2026年4月10日，公司股东户数为33,535","url":"https://stock-news.laohu8.com/highlight/detail?id=2627039298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627039298?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:42","pubTimestamp":1776328944,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)04月16日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好。请问贵公司，截至2026年4月10日的股东的具体的人数？谢谢！莱美药业回复：尊敬的投资者，您好。截至2026年4月10日，公司股东户数为33,535。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600029379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625993633","title":"莱美药业（300006）披露股票交易异常波动公告，4月7日股价下跌7.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625993633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625993633?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:07","pubTimestamp":1775552832,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，莱美药业报收于6.02元，较前一交易日下跌7.67%，最新总市值为63.57亿元。该股当日开盘6.23元，最高6.65元，最低5.96元，成交额达11.89亿元，换手率为18.24%。公司于近日披露《关于股票交易异常波动的公告》。公告显示，莱美药业股票于2026年4月1日至4月3日连续三个交易日内收盘价涨幅偏离值累计达到30%，构成股票交易异常波动。公司确认目前无任何应披露而未披露事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700023617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624665400","title":"莱美药业最新公告：公司及控股股东不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2624665400","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624665400?lang=zh_cn&edition=full","pubTime":"2026-04-03 19:10","pubTimestamp":1775214641,"startTime":"0","endTime":"0","summary":"莱美药业(300006.SZ)公告称，公司股票于4月1日至4月3日连续三个交易日内收盘价涨幅偏离值累计达到30%，属于股票交易异常波动。经核查，公司前期披露信息无需更正，近期经营情况及内外部经营环境未发生重大变化，公司及控股股东不存在应披露而未披露的重大事项，控股股东在异常波动期间未买卖公司股票。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300036726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623631243","title":"股市必读：3月27日莱美药业发布公告，股东减持0万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623631243","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623631243?lang=zh_cn&edition=full","pubTime":"2026-03-30 06:02","pubTimestamp":1774821741,"startTime":"0","endTime":"0","summary":"公司公告汇总关于持股5%以上股东被动减持期限届满的公告重庆莱美药业股份有限公司于2026年3月27日发布公告，持股5%以上股东邱宇因与国海证券股份有限公司质押式回购业务债务逾期，导致其股份被司法执行被动减持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000001272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823639","title":"3月27日莱美药业发布公告，股东减持0万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622823639?lang=zh_cn&edition=full","pubTime":"2026-03-27 19:01","pubTimestamp":1774609315,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日莱美药业发布公告《莱美药业:关于持股5%以上股东被动减持期限届满的公告》，其股东邱宇于2025年12月27日至2026年3月26日间合计减持0.0万股，占公司目前总股本的0.0%，变动期间该股股价下跌7.22%，截止3月26日收盘报4.88元。股东增减持详情见下表：根据莱美药业2025年年报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700041137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622043217","title":"三部门发文规范中医药服务管理；药监局助力器械临床创新成果转化","url":"https://stock-news.laohu8.com/highlight/detail?id=2622043217","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622043217?lang=zh_cn&edition=full","pubTime":"2026-03-25 10:06","pubTimestamp":1774404374,"startTime":"0","endTime":"0","summary":"政策动向三部门发文规范基层医疗卫生机构中医药服务管理3月24日，国家中医药局、国家卫生健康委、国家疾控局联合发布《乡镇卫生院社区卫生服务中心中医药服务管理基本规范》，明确乡镇卫生院、社区卫生服务中心应能提供中药饮片、针刺、艾灸、刮痧砭术、拔罐、中医微创、推拿、敷熨熏浴、骨伤、肛肠等项目中的6类10项以上中医药技术方法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253683741047.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253683741047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK0239","TLX","300006","BK0070","688658"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621870050","title":"莱美药业最新公告：注射用氨曲南通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2621870050","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621870050?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:00","pubTimestamp":1774342830,"startTime":"0","endTime":"0","summary":"莱美药业公告称，公司近日收到国家药监局核准签发的注射用氨曲南《药品补充申请批准通知书》，该产品已通过仿制药质量和疗效一致性评价，并同意变更注册标准、直接接触药品的包装材料和容器，以及有效期和贮藏条件。该药品适用于治疗敏感革兰氏阴性菌引起的多种感染，截至目前国内已有13家企业通过该品种一致性评价。公司表示，此次获批有助于提升产品市场竞争力，但受政策、招标及市场环境等因素影响，销售存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400027998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621039803","title":"莱美药业：截至2026年3月20日，公司股东户数为28,245","url":"https://stock-news.laohu8.com/highlight/detail?id=2621039803","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621039803?lang=zh_cn&edition=full","pubTime":"2026-03-24 09:12","pubTimestamp":1774314738,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止3月20日公司股东人数是多少？莱美药业回复：尊敬的投资者，您好。截至2026年3月20日，公司股东户数为28,245。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400007093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620273502","title":"股市必读：莱美药业年报 - 第四季度单季净利润同比下降44.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620273502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620273502?lang=zh_cn&edition=full","pubTime":"2026-03-20 02:23","pubTimestamp":1773944589,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动近日莱美药业披露，截至2026年3月10日公司股东户数为2.81万户，较2月28日减少143.0户，减幅为0.51%。经营活动产生的现金流量净额为26,037,754.68元，同比下降85.93%。2025年度财务决算报告重庆莱美药业股份有限公司2025年度财务决算报告显示，公司全年实现营业总收入77,568.62万元，同比下降2.50%；营业利润-14,616.91万元，净利润-12,653.19万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000002140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258133","title":"莱美药业(300006.SZ)发布2025年度业绩，归母净亏损1.35亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258133","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620258133?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:47","pubTimestamp":1773834444,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布2025年年度报告，该公司营业收入为7.76亿元，同比减少2.50%。归属于上市公司股东的净亏损为1.35亿元，同比扩大。归属于上市公司股东的扣除非经常性损益的净亏损为1.39亿元。基本每股亏损为0.1276元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415563.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"莱美药业(300006.SZ)发布2025年度业绩，归母净亏损1.35亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0070","300006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619178278","title":"每周股票复盘：中恒集团（600252）莱美药业拟投500万设生物医药基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2619178278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619178278?lang=zh_cn&edition=full","pubTime":"2026-03-15 03:10","pubTimestamp":1773515421,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，中恒集团报收于2.62元，较上周的2.57元上涨1.95%。本周，中恒集团3月12日盘中最高价报2.65元。广西梧州中恒集团股份有限公司董事会于2026年3月13日收到董事刘龙先生的辞职报告，因其工作安排原因，辞去公司董事及董事会相关专门委员会委员职务，辞职后不再担任公司任何职务。辞职报告自送达董事会之日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0028","BK0012","BK0070","600252","160635","BK0077","BK0239","BK0015","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949248","title":"莱美药业最新公告：参与投资设立创业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618949248?lang=zh_cn&edition=full","pubTime":"2026-03-11 19:11","pubTimestamp":1773227495,"startTime":"0","endTime":"0","summary":"莱美药业(300006.SZ)公告称，公司拟与西安沃杰等合作方共同出资设立广州圣泉百杰创业投资基金合伙企业（有限合伙），公司作为有限合伙人认缴出资500万元，占比3.33%。该基金规模为1.5亿元，主要投向创新生物医药、医疗器械、体外诊断等生命健康领域。此次投资不构成关联交易或重大资产重组。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100033455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618917493","title":"莱美药业：截至2026年3月10日，公司股东户数为28,115","url":"https://stock-news.laohu8.com/highlight/detail?id=2618917493","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618917493?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:57","pubTimestamp":1773219429,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至3月10日的股东人数是多少？谢谢莱美药业回复：尊敬的投资者，您好。截至2026年3月10日，公司股东户数为28,115。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100027496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779180722217,"stockEarnings":[{"period":"1week","weight":-0.0866},{"period":"1month","weight":-0.0711},{"period":"3month","weight":0.1784},{"period":"6month","weight":0.1602},{"period":"1year","weight":0.7171},{"period":"ytd","weight":0.1693}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0198},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0468},{"period":"1year","weight":0.2269},{"period":"ytd","weight":0.041}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆莱美药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24958人(较上一季度增加0.28%)","perCapita":"42303股","listingDate":"2009-10-30","address":"重庆市南岸区玉马路99号","registeredCapital":"105591万元","survey":" 重庆莱美药业股份有限公司的主营业务是医药制造。公司的主要产品是化药，涵盖特色专科类（主要包括抗肿瘤药、消化系统药、肠外营养药）、抗感染类等。","listedPrice":16.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱美药业,300006,莱美药业股票,莱美药业股票老虎,莱美药业股票老虎国际,莱美药业行情,莱美药业股票行情,莱美药业股价,莱美药业股市,莱美药业股票价格,莱美药业股票交易,莱美药业股票购买,莱美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}